In addition, Vazquez et al. demonstrated that in vitro pharmacological treatment with hemin of androgen-sensitive (LNCaP) and androgen-insensitive (PC3) prostate cancer cell lines induced HO-1 overexpression and its nuclear translocation in both tumor subtypes [67]. The gene discussed is HMOX1; the disease is prostate cancer.